Completed PHASE4 INTERVENTIONAL 2-arm NCT02317601

Preoperative Single Glucocorticoid Hip Fracture Hip Fracture Surgery

Preoperative Single-high Dose Glucocorticoid for Patients Undergoing Hip Fracture Surgery and the Effect on Postoperative Delirium.

Sponsor: Hvidovre University Hospital

Conditions Delirium - Postoperative Stress, Physiological

Interventions methylprednisolone sodium succinate placebo saline

Updated 6 times since 2017 Last updated: Jul 15, 2016 Started: Dec 31, 2014 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02317601, this PHASE4 trial focuses on Delirium - Postoperative and Stress, Physiological and remains completed. Sponsored by Hvidovre University Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hvidovre University Hospital

Data source: Hvidovre University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hvidovre, Denmark